Document Detail

The usefulness of narrowband UVB as a monotherapy for the treatment of chronic plaque psoriasis.
MedLine Citation:
PMID:  20684149     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To assess the efficacy and safety of narrowband ultraviolet B (UVB) phototherapy in dark-skinned Saudi patients with chronic plaque psoriasis. PATIENTS AND METHODS: This prospective study was performed on 63 patients of chronic plaque psoriasis attending Qassim University clinics from May 2004 through June 2009. Narrowband UVB irradiation was done three times per week using the 311 +/- 2 nm wavelength. RESULTS: Approximately 79 percent of patients achieved disease clearance (i.e., 90% or more reduction in PASI scores). The response to treatment was significantly better in females compared to males. No serious side effects were observed. CONCLUSION: The narrowband UVB phototherapy was found to be safe and effective in darker-skinned Saudi patients with chronic plaque psoriasis, especially among females. A longer period of treatment (minimum of six months) is recommended for complete clearance of psoriasis.
Ahmad A Al Robaee
Related Documents :
857739 - The hla system and the arthropathies associated with psoriasis.
17543159 - Vascular endothelial growth factor in patients with psoriatic arthritis.
6839929 - The lens and puva therapy.
17574299 - Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 pati...
22207839 - Modeling accuracy and variability of motor timing in treated and untreated parkinson's ...
3266069 - Alpha 1-proteinase inhibitor in psoriasis: reduced activity in symptom-free patients an...
7578489 - Bioelectrical impedance analysis and dual energy x-ray absorptiometry to monitor nutrit...
23294009 - Vertebrobasilar dolichoectasia as a risk factor for cerebral microbleeds.
3925569 - Clinical evaluation of a '3-in-1' intravenous nutrient solution.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of drugs in dermatology : JDD     Volume:  9     ISSN:  1545-9616     ISO Abbreviation:  J Drugs Dermatol     Publication Date:  2010 Aug 
Date Detail:
Created Date:  2010-08-05     Completed Date:  2010-08-19     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101160020     Medline TA:  J Drugs Dermatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  989-91     Citation Subset:  IM    
Department of Dermatology, College of Medicine, Qassim University, Buraidah, Saudi Arabia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Chronic Disease
Middle Aged
Prospective Studies
Psoriasis / pathology,  therapy*
Saudi Arabia
Sex Factors
Skin Pigmentation*
Time Factors
Ultraviolet Therapy / adverse effects,  methods*
Young Adult

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Use of biologic agents in pediatric psoriasis.
Next Document:  An evidence-based review of the efficacy of topical antihistamines in the relief of pruritus.